Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Aug-Sep;26(4):308-19.
doi: 10.1177/1049909109335146. Epub 2009 May 4.

Impact of biopsychosocial factors on chronic pain in persons with myotonic and facioscapulohumeral muscular dystrophy

Affiliations

Impact of biopsychosocial factors on chronic pain in persons with myotonic and facioscapulohumeral muscular dystrophy

Jordi Miró et al. Am J Hosp Palliat Care. 2009 Aug-Sep.

Abstract

To assess the role of biopsychosocial factors in patients with type 1 myotonic and facioscapulohumeral muscular dystrophy (MMD1/FSHD) with chronic pain. Associations between psychosocial factors were found to be important in other samples of persons with pain and both psychological functioning and pain interference in a sample of patients suffering from MMD/FSHD. Prospective, multiple group, survey study of 182 patients with confirmed MMD1 and FSHD. Participants completed surveys assessing pain interference and psychological functioning, as well as psychosocial, demographic, and injury-related variables. Analyses indicated that greater catastrophizing was associated with increased pain interference and poorer psychological functioning, pain attitudes were significantly related to both pain interference and psychological functioning, and coping responses were significantly related only to pain interference. In addition, greater perceived social support was associated with better psychological functioning. The results support the use of studying pain in persons with MMD/FSHD from a biopsychosocial perspective, and the importance of identifying psychosocial factors that may play a role in the adjustment to and response to pain secondary to MMD/FSHD.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Johnson ER, Carter GT, Kilmer DD, et al. Profiles of neuromuscular disease: myotonic muscular dystrophy. Am J Phys Med Rehabil. 1995;74(5):S104–S116. - PubMed
    1. Kilmer DD, Abresch RT, Aitkens SG, et al. Profiles of neuromuscular disease: facioscapulohumeral dystrophy. Am J Phys Med Rehabil. 1995;74(5):S131–S139. - PubMed
    1. Wheeler TM, Thornton CA. Myotonic dystrophy: RNA-mediated muscle disease. Curr Opin Neurol. 2007;20(5):572–576. - PubMed
    1. Feyma T, Carter GT, Weiss MD. Myotonic dystrophy type 1 coexisting with myasthenia gravis and thymoma. Muscle Nerve. 2008;38(1):916–920. - PubMed
    1. McDonald CM, Han JJ, Carter GT. Myopathic Disorders. In: Braddom RL, editor. Physical Medicine and Rehabilitation. 3. Philadelphia, PA: WB Saunders/Elsevier; 2007. pp. 1099–1131.

Publication types

MeSH terms